지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.11
- 수록면
- 1 - 13 (13page)
- DOI
- 10.3346/jkms.2022.37.e324
이용수
초록· 키워드
오류제보하기
Background: The 2017 Korean guideline on community-acquired pneumonia (CAP) recommended beta-lactam plus macrolide combination therapy for patients hospitalized with severe pneumonia, and beta-lactam monotherapy for mild-to-moderate pneumonia.
However, antibiotic treatment regimen for mild-to-moderate CAP has never been evaluated for Korean patients.
Methods: In this retrospective cohort study, study patients were selected from three evaluation periods (October 1 to December 31, 2014; April 1 to June 30, 2016; October 1 to December 31, 2017) of the National Quality Assessment Program for CAP management and the National Health Insurance data on the selected patients was extracted from 1 year before the first patient enrollment and 1 year after the last patient enrollment at each evaluation period for the analysis of risk adjustment and outcomes. The survival rates between beta-lactam plus macrolide (BM) groups and beta-lactam monotherapy (B) were compared using a Kaplan-Meier survival analysis after propensity score matching by age, gender, confusion, urea, respiratory rate, blood pressure at age of 65 years or older (CURB-65), and Charlson comorbidity index for risk adjustment. The differences between autumn and spring season were also evaluated.
Results: A total of 30,053 patients were enrolled. Mean age and the male-to-female ratio were 64.7 ± 18.4 and 14,197:15,856, respectively. After matching, 2,397 patients in each group were analyzed. The 30-day survival rates did not differ between the BM and B groups (97.3% vs. 96.5%, P = 0.081). In patients with CURB-65 ≥ 2, the 30-day survival rate was higher in the BM than in the B group (93.7% vs. 91.0%, P = 0.044). Among patients with CURB-65 ≥ 2, the 30-day survival rate was higher in the BM than in the B group (93.3% vs. 88.5%, P = 0.009) during autumn season, which was not observed during spring (94.2% vs. 94.1%, P = 0.986).
Conclusion: Beta-lactam plus macrolide combination therapy shows potential as an empirical therapy for CAP with CURB-65 ≥ 2, especially in autumn.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis
Journal of Korean Medical Science
2017 .01
-
[Microbiology] Molecular characteristics of ESBLproducing Escherichia coli isolated from chickens with colibacillosis
Journal of Veterinary Science
2022 .05
-
Predicting 30-day mortality of patients with pneumonia in an emergency department setting using machine-learning models
Clinical and Experimental Emergency Medicine
2020 .01
-
Antibiotic Treatment of Vertebral Osteomyelitis caused by Methicillin-Susceptible Staphylococcus aureus: A Focus on the Use of Oral β-lactams
Infection and Chemotherapy
2019 .01
-
Proportion of Aspiration Pneumonia Cases Among Patients With Community-Acquired Pneumonia: A Single-Center Study in Korea
Annals of Rehabilitation Medicine
2019 .01
-
응급실에 입원한 지역사회획득 폐렴 노인환자에서 lactate와 SMART-COP조합의 예후 예측 능력
대한응급의학회지
2020 .01
-
Prolonged versus Intermittent Infusion of β-Lactams for the Treatment of Nosocomial Pneumonia: A Meta- Analysis
Infection and Chemotherapy
2016 .01
-
Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections
Yonsei Medical Journal
2022 .07
-
응급실 내원 환자 중 지역사회획득 폐렴 발생 환자수와 기상 요소와의 연관성: 엘라스틱 넷 변수 선택 기법을 이용한 포아송 회귀분석
대한응급의학회지
2016 .01
-
Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study
Clinical and Experimental Emergency Medicine
2022 .03
-
Macrolide Resistance and Its Impacts on M. Pneumoniae Pneumonia in Children: Comparison of Two Recent Epidemics in Korea
Allergy, Asthma & Immunology Research
2017 .01
-
Clavulanic Acid Is a Leading Culprit Beta-Lactam in Immediate Allergic Reactions to Penicillins
Allergy, Asthma & Immunology Research
2023 .03
-
Estimating the Survival of Patients With Lung Cancer: What Is the Best Statistical Model?
예방의학회지
2019 .01
-
Evaluation of the Quality of Care among Hospitalized Adult Patients with Community-Acquired Pneumonia in Korea
Tuberculosis and Respiratory Diseases
2018 .01
-
Estimation of Survival Rates in Patients with Lung Cancer in West Azerbaijan, the Northwest of Iran
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Development of Individual Survival Estimating Program for Cancer Patients’ Management
Healthcare Informatics Research
2015 .01
-
Wanted: The Best Second Option to Treat Macrolide-Unresponsive Mycoplasmal Pneumonia in Children
Journal of Korean Medical Science
2018 .01
-
Active Treatment Improves Overall Survival in Extremely Older Non-Small Cell Lung Cancer Patients: A Multicenter Retrospective Cohort Study
Cancer Research and Treatment
2021 .01
-
증가하는 마크로라이드에 반응하지 않는 마이코플라스마 폐렴의 관련 인자와 임상 양상의 변화
Allergy Asthma & Respiratory Diseases
2018 .01
-
마이코플라스마 폐렴에서 조기 스테로이드 사용의 유용성
Allergy Asthma & Respiratory Diseases
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0